WallStSmart

MercadoLibre Inc. (MELI)vsXpeng Inc (XPEV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Xpeng Inc generates 114% more annual revenue ($75.41B vs $35.18B). MELI leads profitability with a 5.3% profit margin vs -4.1%. MELI earns a higher WallStSmart Score of 60/100 (C+).

MELI

Buy

60

out of 100

Grade: C+

Growth: 7.3Profit: 6.0Value: 6.7Quality: 4.0
Piotroski: 2/9Altman Z: 1.35

XPEV

Avoid

32

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 6.7Quality: 4.5
Piotroski: 6/9Altman Z: 0.43
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MELIUndervalued (+64.8%)

Margin of Safety

+64.8%

Fair Value

$5728.38

Current Price

$1897.37

$3831.01 discount

UndervaluedFair: $5728.38Overvalued
XPEVUndervalued (+85.0%)

Margin of Safety

+85.0%

Fair Value

$120.81

Current Price

$10.54

$110.27 discount

UndervaluedFair: $120.81Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MELI5 strengths · Avg: 8.8/10
Revenue GrowthGrowth
49.8%10/10

Revenue surging 49.8% year-over-year

Market CapQuality
$96.19B9/10

Large-cap with strong market position

Return on EquityProfitability
23.8%9/10

Every $100 of equity generates 24 in profit

PEG RatioValuation
0.928/10

Growing faster than its price suggests

Free Cash FlowQuality
$3.39B8/10

Generating 3.4B in free cash flow

XPEV1 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Areas to Watch

MELI4 concerns · Avg: 3.3/10
Price/BookValuation
12.3x4/10

Trading at 12.3x book value

Profit MarginProfitability
5.3%3/10

5.3% margin — thin

Debt/EquityHealth
1.683/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

XPEV4 concerns · Avg: 2.3/10
Debt/EquityHealth
1.513/10

Elevated debt levels

Return on EquityProfitability
-11.5%2/10

ROE of -11.5% — below average capital efficiency

EPS GrowthGrowth
-10.2%2/10

Earnings declined 10.2%

Altman Z-ScoreHealth
0.432/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : MELI

The strongest argument for MELI centers on Revenue Growth, Market Cap, Return on Equity. Revenue growth of 49.8% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bull Case : XPEV

The strongest argument for XPEV centers on Price/Book.

Bear Case : MELI

The primary concerns for MELI are Price/Book, Profit Margin, Debt/Equity. A P/E of 51.8x leaves little room for execution misses. Debt-to-equity of 1.68 is elevated, increasing financial risk.

Bear Case : XPEV

The primary concerns for XPEV are Debt/Equity, Return on Equity, EPS Growth. Debt-to-equity of 1.51 is elevated, increasing financial risk.

Key Dynamics to Monitor

MELI profiles as a hypergrowth stock while XPEV is a turnaround play — different risk/reward profiles.

MELI carries more volatility with a beta of 1.31 — expect wider price swings.

MELI is growing revenue faster at 49.8% — sustainability is the question.

Monitor INTERNET RETAIL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MELI scores higher overall (60/100 vs 32/100) and 49.8% revenue growth. XPEV offers better value entry with a 85.0% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MercadoLibre Inc.

CONSUMER CYCLICAL · INTERNET RETAIL · USA

MercadoLibre, Inc. operates online trading platforms in Latin America. The company is headquartered in Buenos Aires, Argentina.

Xpeng Inc

CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA

XPeng Inc. designs, develops, manufactures and markets smart electric vehicles in the People's Republic of China. The company is headquartered in Guangzhou, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?